We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.44B
AUM Growth
-$465M
Cap. Flow
-$442M
Cap. Flow %
-30.7%
Top 10 Hldgs %
11.9%
Holding
1,595
New
313
Increased
337
Reduced
470
Closed
413

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Healthcare 10.93%
3 Consumer Discretionary 9.87%
4 Industrials 9.31%
5 Financials 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWK icon
326
Cushman & Wakefield Ltd
CWK
$3.25B
$962K 0.07%
92,498
-40,567
-30% -$419K
ARWR icon
327
Arrowhead Research
ARWR
$12.4B
$960K 0.07%
36,929
+24,229
+191% +$595K
TFPM icon
328
Triple Flag Precious Metals
TFPM
$6.72B
$957K 0.07%
61,758
RBLX icon
329
Roblox
RBLX
$27B
$953K 0.07%
25,609
+14,259
+126% +$508K
KKR icon
330
KKR & Co
KKR
$92.3B
$950K 0.07%
9,025
+4,825
+115% +$491K
AEM icon
331
Agnico Eagle Mines
AEM
$90.5B
$948K 0.07%
14,493
+3,071
+27% +$200K
LLYVA icon
332
Liberty Live Group Series A
LLYVA
$9.09B
$936K 0.07%
24,966
+1,386
+6% +$51.9K
KRE icon
333
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
$933K 0.06%
+19,000
New +$917K
AMZU icon
334
Direxion Daily AMZN Bull 2X ETF
AMZU
$384M
$933K 0.06%
+25,000
New +$865K
AUTL
335
Autolus Therapeutics
AUTL
$562M
$928K 0.06%
+266,692
New +$1.15M
PM icon
336
Philip Morris
PM
$295B
$916K 0.06%
+9,044
New +$884K
VTI icon
337
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$915K 0.06%
+3,420
New +$885K
WIX icon
338
WIX.com
WIX
$2.52B
$911K 0.06%
5,730
+2,253
+65% +$324K
EME icon
339
Emcor
EME
$36B
$910K 0.06%
2,493
-5,198
-68% -$1.92M
GDX icon
340
VanEck Gold Miners ETF
GDX
$27.4B
$906K 0.06%
26,705
+5,456
+26% +$187K
GS icon
341
CALL
Goldman Sachs
GS
$303B
$905K 0.06%
2,000
-100
-5% -$43.9K
GS icon
342
PUT
Goldman Sachs
GS
$303B
$905K 0.06%
2,000
-100
-5% -$43.9K
XOM icon
343
ExxonMobil
XOM
$634B
$900K 0.06%
7,819
-29,410
-79% -$3.43M
WCN
344
Waste Connections
WCN
$42B
$882K 0.06%
5,028
-3,817
-43% -$638K
TVTX icon
345
Travere Therapeutics
TVTX
$5.78B
$881K 0.06%
107,222
+24,800
+30% +$167K
IVT icon
346
InvenTrust Properties
IVT
$2.59B
$879K 0.06%
35,493
-5,876
-14% -$145K
AMD icon
347
Advanced Micro Devices
AMD
$789B
$878K 0.06%
5,411
-34,289
-86% -$5.52M
MS icon
348
CALL
Morgan Stanley
MS
$340B
$875K 0.06%
9,000
-2,000
-18% -$190K
MS icon
349
PUT
Morgan Stanley
MS
$340B
$875K 0.06%
9,000
-2,000
-18% -$190K
LITE icon
350
Lumentum
LITE
$69.3B
$869K 0.06%
17,070
+6,987
+69% +$317K

Similar funds

Prelude Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Prelude Capital Management held 1,595 positions worth $1.44B, down 24% from $1.91B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $442M in Q2 2024, closing 413 positions and reducing 470 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Constellation Energy worth $6.37M.

  • Prelude Capital Management's largest Q2 2024 buy was Constellation Energy: 31,786 shares worth $6.37M.
  • Prelude Capital Management added most to Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024, an estimated $6.05M increase.
  • Prelude Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $13.1M.
  • Prelude Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $16.5M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.44B portfolio in Q2 2024.
  • Prelude Capital Management opened 313 new positions and closed 413 in Q2 2024.
  • Prelude Capital Management's portfolio value fell 24% quarter-over-quarter to $1.44B.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.